RIFAMPICIN INDUCED PURE RED CELL APLASIA
Abstract
BACKGROUND Pure red cell aplasia (PRCA) is a rare condition of severe anemia characterized by anabsence of erythroid precursor in the bone marrow, severe reticulocytopenia and normalplatelet and leukocyte count. This condition appears as an acquired defect of either acuteor chronic type, and a congenital form. The acquired form occurs in association with autoimmune or lymphoproliferative disorders, and we discover thymoma in 5 % of patients.The acute acquired form is associated with some hemolytic disorders, infections and mayoccur with the use of certain drugs.Patient and The article presents a 53-year old patient who developed a severe form of anemia withmethods reticulocytopenia while he was being treated with vancomycin and rifampicin antibiotics.Because of the end stage renal failure he is on chronic hemodyalisis and is treated witherythropoietin. He is also infected by hepatitis C virus.The virtual absence of erythroidprecursor in the bone marrow lead us to presume a PRCA. The other causes of anemiawere ruled out with the absence of antibodies against erythropoietin and Ig M antibodiesto parvovirus B 19. After withdrawal of treatment with antibiotics and introduction oftreatment with immunoglobulins the patient completely recovered and is anemia – free. CONCLUSIONS During the course of infections anemia could be the consequence of treatment with antibiotics and other drugs. The diagnosis is confirmed predominantly by bone marrow examinationDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.